Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.
about
Nanotechnology: Future of OncotherapyA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsNanotechnology applications in urology: a reviewLong circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapyFolate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistanceSingle-step surface functionalization of polymeric nanoparticles for targeted drug delivery.Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.Signaling pathways in spermatogonial stem cells and their disruption by toxicantsIn vitro cytotoxicity of nanoparticles in mammalian germline stem cells.Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticlesInterfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.Bioengineering strategies for designing targeted cancer therapiesCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugsBiomedical potential of silver nanoparticles synthesized from calli cells of Citrullus colocynthis (L.) Schrad.Impact of nanotechnology in cancer: emphasis on nanochemopreventionIn vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.An RNA alternative to human transferrin: a new tool for targeting human cells.Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy.Targeted drug delivery in cancer therapy.Dual-imaging enabled cancer-targeting nanoparticles.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots.Biodegradable nanoparticles for cytosolic delivery of therapeutics.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationInhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.Paclitaxel Nano-Delivery Systems: A Comprehensive Review."Clickable" polymer nanoparticles: a modular scaffold for surface functionalization.Ligand-based targeted therapy for cancer tissue.Nanotechnology in urologyNanoformulation of natural products for prevention and therapy of prostate cancer.Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.Nanotechnology and its relationship to interventional radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention.Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
P2860
Q26801067-825B0E3D-A93E-4F97-AC92-153622B3FCC6Q27006569-5FE4A2E3-759F-4FC8-B413-5A9B2DFD75C0Q27009446-497F7520-5195-4903-A5D1-0A6CF702F09BQ28477996-9214E800-3180-42F8-AA9A-18090E4FA492Q28481616-A6E92CCB-6938-4A63-A364-3297B74EA510Q33385557-DA4A4484-B064-4F49-AF28-429932FFD4D5Q33918405-83411DDD-7DA2-48DA-8FF6-761C50170CA0Q34005745-6F817A73-D2BA-425B-97E0-FDA82B2C1E85Q34025003-9B5AD8A7-51DF-44B3-A723-5E91FE7A8BA8Q34028831-92C6B2E2-B1EB-4C7B-8A32-9AEB53E0BD76Q34036920-41EA6B79-8D3B-4E24-8CE3-4516A47EBD66Q34194191-49DA7973-EC81-420F-8B0A-E2601DA69845Q34447986-762452E3-9A36-4DFA-BD73-5BEA4BCE2B6AQ34534023-D163125D-0B31-47FB-977F-D2916C0062B6Q34615075-D82A5871-5412-4BF7-AF48-708F1886D6B0Q34818171-A4A66F79-1CE5-4153-9D19-1A3F6D7D6E0DQ35461452-3B5B5A32-FD90-4773-B28B-0BF7C539DB77Q35750624-4AEF738F-8567-4622-A25E-7E7ED13CDD4FQ35797531-F7D674E7-5258-4F36-A351-4602F99F8359Q35972569-15B745EA-46D2-4162-808B-8E0D0DA67312Q36077849-E556EAA3-AD83-4E5A-8947-C1652F9DA422Q36152452-4D9E7171-2DCD-4B30-9C03-01F52560ED58Q36200150-8328E64A-B8D8-44BA-A5A0-6B2FF89CB44EQ36304364-50A76621-0E2D-4F63-9D09-A0FEB70EBEF2Q36406637-BBEF1801-E55A-405B-A146-96BD96DE7170Q36422280-68111790-0BE0-42BB-8C2C-7815C5181330Q36904010-A779B6B4-ACAF-40D0-A3F2-414D1C6099AEQ36934007-0E4BEE9F-5293-4917-8F3E-3763FA72713AQ36971463-BF11B4DD-D4AF-4A35-9150-D2649C102F20Q37148172-AF780526-D33B-45B6-A1D1-519651907495Q37250009-C9D962A7-7A6A-4FD2-8622-77B9DFA35428Q37389368-90727D0E-E797-43F4-920A-AB7858281F40Q37425224-D56ACB14-6DB4-4C49-BAA2-180A3736F32EQ37465592-332369E3-235C-4E31-B684-8E7C6DCB68C3Q37473193-29ED8488-CA1D-4DCE-8EEF-07CC2AFEEA46Q37668316-0927C2CB-64EB-41D4-AABB-0ACB55E17E5FQ37703236-DDC9576C-F828-49BC-A509-077AB5E23BADQ37789181-8A5EBC41-319C-4FE5-A1C8-0203564D5CF4Q37885883-3B53B347-5BCC-4A53-94F1-A7692A92C7C9Q38067265-9158760E-CC0E-41AE-820A-C0FB50BE8C45
P2860
Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Efficacy of transferrin-conjug ...... rine model of prostate cancer.
@en
type
label
Efficacy of transferrin-conjug ...... rine model of prostate cancer.
@en
prefLabel
Efficacy of transferrin-conjug ...... rine model of prostate cancer.
@en
P2093
P356
P1476
Efficacy of transferrin-conjug ...... rine model of prostate cancer.
@en
P2093
Sanjeeb K Sahoo
Vinod Labhasetwar
P304
P356
10.1002/IJC.20405
P577
2004-11-01T00:00:00Z